Found: 6
Select item for more details and to access through your institution.
Efficacy and Safety of Synbiotics in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Randomized, Double-blinded, Placebo-controlled Pilot Study.
- Published in:
- Internal Medicine, 2023, v. 62, n. 20, p. 2949, doi. 10.2169/internalmedicine.1314-22
- By:
- Publication type:
- Article
A Pathogenic NRAS c.38G>A (p.G13D) Mutation in RARA Translocation-negative Acute Promyelocytic-like Leukemia with Concomitant Myelodysplastic Syndrome.
- Published in:
- Internal Medicine, 2023, v. 62, n. 9, p. 1329, doi. 10.2169/internalmedicine.0174-22
- By:
- Publication type:
- Article
Discontinuation of sorafenib can lead to the emergence of FLT3-ITD-positive acute myeloid leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 2010, doi. 10.1177/1078155218816768
- By:
- Publication type:
- Article
An mTORC1/2 dual inhibitor, AZD2014, acts as a lysosomal function activator and enhances gemtuzumab ozogamicin-induced apoptosis in primary human leukemia cells.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Regorafenib-induced exacerbation of chronic immune thrombocytopenic purpura in remission: A case report.
- Published in:
- Molecular & Clinical Oncology, 2021, v. 14, n. 2, p. N.PAG
- By:
- Publication type:
- Article
GSK3 inhibitor enhances gemtuzumab ozogamicin‐induced apoptosis in primary human leukemia cells by overcoming multiple mechanisms of resistance.
- Published in:
- EJHaem, 2023, v. 4, n. 1, p. 153, doi. 10.1002/jha2.600
- By:
- Publication type:
- Article